FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213103525> ?p ?o ?g. }

• W4213103525 endingPage "5658" @default.
• W4213103525 startingPage "5645" @default.
• W4213103525 abstract "Abstract Context Cancer prevalence is increasing, with many patients requiring opioid analgesia. Clinicians need to ensure patients receive adequate pain relief. However, opioid misuse is widespread, and cancer patients are at risk. Objectives This study aims (1) to identify screening approaches that have been used to assess and monitor risk of opioid misuse in patients with cancer; (2) to compare the prevalence of risk estimated by each of these screening approaches; and (3) to compare risk factors among demographic and clinical variables associated with a positive screen on each of the approaches. Methods Medline, Cochrane Controlled Trial Register, PubMed, PsycINFO, and Embase databases were searched for articles reporting opioid misuse screening in cancer patients, along with handsearching the reference list of included articles. Bias was assessed using tools from the Joanna Briggs Suite. Results Eighteen studies met the eligibility criteria, evaluating seven approaches: Urine Drug Test (UDT) ( n = 8); the Screener and Opioid Assessment for Patients with Pain (SOAPP) and two variants, Revised and Short Form ( n = 6); the Cut-down, Annoyed, Guilty, Eye-opener (CAGE) tool and one variant, Adapted to Include Drugs ( n = 6); the Opioid Risk Tool (ORT) ( n = 4); Prescription Monitoring Program (PMP) ( n = 3); the Screen for Opioid-Associated Aberrant Behavior Risk (SOABR) ( n = 1); and structured/specialist interviews ( n = 1). Eight studies compared two or more approaches. The rates of risk of opioid misuse in the studied populations ranged from 6 to 65%, acknowledging that estimates are likely to have varied partly because of how specific to opioids the screening approaches were and whether a single or multi-step approach was used. UDT prompted by an intervention or observation of aberrant opioid behaviors (AOB) were conclusive of actual opioid misuse found to be 6.5–24%. Younger age, found in 8/10 studies; personal or family history of anxiety or other mental ill health, found in 6/8 studies; and history of illicit drug use, found in 4/6 studies, showed an increased risk of misuse. Conclusions Younger age, personal or familial mental health history, and history of illicit drug use consistently showed an increased risk of opioid misuse. Clinical suspicion of opioid misuse may be raised by data from PMP or any of the standardized list of AOBs. Clinicians may use SOAPP-R, CAGE-AID, or ORT to screen for increased risk and may use UDT to confirm suspicion of opioid misuse or monitor adherence. More research into this important area is required. Significance of results This systematic review summarized the literature on the use of opioid misuse risk approaches in people with cancer. The rates of reported risk range from 6 to 65%; however, true rate may be closer to 6.5–24%. Younger age, personal or familial mental health history, and history of illicit drug use consistently showed an increased risk of opioid misuse. Clinicians may choose from several approaches. Limited data are available on feasibility and patient experience. PROSPERO registration number. CRD42020163385." @default.
• W4213103525 created "2022-02-24" @default.
• W4213103525 creator A5043664014 @default.
• W4213103525 creator A5053565464 @default.
• W4213103525 creator A5078897033 @default.
• W4213103525 creator A5081215319 @default.
• W4213103525 creator A5084472266 @default.
• W4213103525 creator A5088776128 @default.
• W4213103525 date "2022-02-15" @default.
• W4213103525 modified "2023-09-27" @default.
• W4213103525 title "A systematic review of assessment approaches to predict opioid misuse in people with cancer" @default.
• W4213103525 cites W1514300820 @default.
• W4213103525 cites W1599285145 @default.
• W4213103525 cites W1739175964 @default.
• W4213103525 cites W1808713971 @default.
• W4213103525 cites W1968189159 @default.
• W4213103525 cites W1972242861 @default.
• W4213103525 cites W1972589489 @default.
• W4213103525 cites W1973396925 @default.
• W4213103525 cites W1994668368 @default.
• W4213103525 cites W2002450821 @default.
• W4213103525 cites W2005257994 @default.
• W4213103525 cites W2013939100 @default.
• W4213103525 cites W2034849337 @default.
• W4213103525 cites W2035676646 @default.
• W4213103525 cites W2054897163 @default.
• W4213103525 cites W2059471641 @default.
• W4213103525 cites W2069409783 @default.
• W4213103525 cites W2096164040 @default.
• W4213103525 cites W2103904625 @default.
• W4213103525 cites W2108802610 @default.
• W4213103525 cites W2116346640 @default.
• W4213103525 cites W2131826103 @default.
• W4213103525 cites W2143470297 @default.
• W4213103525 cites W2155657813 @default.
• W4213103525 cites W2157260243 @default.
• W4213103525 cites W2211101095 @default.
• W4213103525 cites W2270243513 @default.
• W4213103525 cites W2312966816 @default.
• W4213103525 cites W2373788992 @default.
• W4213103525 cites W2382144598 @default.
• W4213103525 cites W2415306087 @default.
• W4213103525 cites W2567687310 @default.
• W4213103525 cites W2576440140 @default.
• W4213103525 cites W2582300194 @default.
• W4213103525 cites W2588681363 @default.
• W4213103525 cites W2739533923 @default.
• W4213103525 cites W2745466633 @default.
• W4213103525 cites W2746450265 @default.
• W4213103525 cites W2790983564 @default.
• W4213103525 cites W2885019613 @default.
• W4213103525 cites W2891416276 @default.
• W4213103525 cites W2896801398 @default.
• W4213103525 cites W2940833969 @default.
• W4213103525 cites W2942632282 @default.
• W4213103525 cites W2944311729 @default.
• W4213103525 cites W2965434914 @default.
• W4213103525 cites W2979278957 @default.
• W4213103525 cites W2994750398 @default.
• W4213103525 cites W3002849926 @default.
• W4213103525 cites W3004594412 @default.
• W4213103525 cites W3008055034 @default.
• W4213103525 cites W3086319830 @default.
• W4213103525 cites W3108041409 @default.
• W4213103525 cites W3118701973 @default.
• W4213103525 cites W4231661401 @default.
• W4213103525 cites W4254121089 @default.
• W4213103525 doi "https://doi.org/10.1007/s00520-022-06895-w" @default.
• W4213103525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35166898" @default.
• W4213103525 hasPublicationYear "2022" @default.
• W4213103525 type Work @default.
• W4213103525 citedByCount "1" @default.
• W4213103525 countsByYear W42131035252023 @default.
• W4213103525 crossrefType "journal-article" @default.
• W4213103525 hasAuthorship W4213103525A5043664014 @default.
• W4213103525 hasAuthorship W4213103525A5053565464 @default.
• W4213103525 hasAuthorship W4213103525A5078897033 @default.
• W4213103525 hasAuthorship W4213103525A5081215319 @default.
• W4213103525 hasAuthorship W4213103525A5084472266 @default.
• W4213103525 hasAuthorship W4213103525A5088776128 @default.
• W4213103525 hasBestOaLocation W42131035251 @default.
• W4213103525 hasConcept C121608353 @default.
• W4213103525 hasConcept C126322002 @default.
• W4213103525 hasConcept C151730666 @default.
• W4213103525 hasConcept C170493617 @default.
• W4213103525 hasConcept C17744445 @default.
• W4213103525 hasConcept C199539241 @default.
• W4213103525 hasConcept C2426938 @default.
• W4213103525 hasConcept C2778904085 @default.
• W4213103525 hasConcept C2779343474 @default.
• W4213103525 hasConcept C2779473830 @default.
• W4213103525 hasConcept C2779549880 @default.
• W4213103525 hasConcept C2781063702 @default.
• W4213103525 hasConcept C512399662 @default.
• W4213103525 hasConcept C71924100 @default.
• W4213103525 hasConcept C86803240 @default.
• W4213103525 hasConcept C98274493 @default.
• W4213103525 hasConceptScore W4213103525C121608353 @default.

• next